Lung cancer is one of the deadly diseases and it causes several deaths around the world. It is one of the leading causes of cancer-related deaths in both men and women, with a 5-year survival rate of only 19%. However, recent advances in cancer treatment have brought hope for lung cancer patients, particularly in the field of immuno-therapy. One of the articles from Cedars Sinai states that immunotherapy drug combination could extend the lives of those diagnosed with advanced non-small cell lung cancer, one of the most common forms of lung cancer.
Companies like Medditour connect the patients seeking immuno-therapy for cancer cure with the global hospitals and facilitators for cost-effective and quality treatments.
In this article, let’s explore in detail about immuno-therapy, how is it done, and how medical tourism in India, Malaysia, and Singapore would help it.
Immuno-therapy: A glimpse
Immuno-therapy stimulates the immune system to identify the cancer cells and attack them. It works by using substances that help the immune system identify and target cancer cells, and can be administered through a variety of methods, including injections, pills, and infusions. Immuno-therapy has been successful in treating a range of cancer types, including melanoma, bladder cancer, and lung cancer.
One of the most promising immuno-therapy drugs for lung cancer is called Pembrolizumab, which has been approved by the US Food and Drug Administration (FDA) for the treatment of non-small cell lung cancer (NSCLC). Pembrolizumab is a type of drug called a checkpoint inhibitor, which blocks a protein that helps cancer cells evade the immune system. By blocking this protein, Pembrolizumab helps the immune system recognize and attack cancer cells.
Medical tourism and immuno-therapy
Countries like India, Singapore, Malaysia, and Thailand have become popular destinations for medical tourism due to their high-quality medical facilities, experienced doctors, and competitive prices.
India has several hospitals that offer world-class cancer treatment, including immuno-therapy. The Tata Memorial Hospital in Mumbai is one such hospital, which has a dedicated immuno-therapy department and has successfully treated many lung cancer patients using Pembrolizumab.
Singapore is another country that has made significant strides in the field of immuno-therapy. The National Cancer Centre Singapore (NCCS) is a leading cancer treatment center that has pioneered several immuno-therapy treatments, including for lung cancer. The NCCS uses a multidisciplinary approach to cancer treatment, which includes a team of doctors, nurses, and researchers who work together to develop personalized treatment plans for each patient.
Malaysia also has several hospitals and clinics that offer immuno-therapy treatments for lung cancer. The Kuala Lumpur General Hospital, for example, has a dedicated cancer center that offers a range of treatments, including immuno-therapy.
Medical tourism platforms like Medditour offer opportunities to cancer patients seeking immuno-therapy to combine their treatment with vacation at the medical tourism destinations, to enable quick recovery.
In conclusion, immuno-therapy has shown great promise in the treatment of lung cancer, and countries like India, Singapore, Malaysia, and Thailand have become centers of excellence for this type of treatment. These countries offer high-quality medical facilities, experienced doctors, and competitive prices, making them attractive destinations for medical tourism. Patients who are considering immuno-therapy for lung cancer should consider these countries as potential treatment options.